These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 11134213

  • 1. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
    Oberlin O, Rey A, Anderson J, Carli M, Raney RB, Treuner J, Stevens MC, International Society of Paediatric Oncology Sarcoma Committee, Intergroup Rhabdomyosarcoma Study Group, Italian Cooperative Soft Tissue Sarcoma Group, German Collaborative Soft Tissue Sarcoma Group.
    J Clin Oncol; 2001 Jan 01; 19(1):197-204. PubMed ID: 11134213
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
    Jenney M, Oberlin O, Audry G, Stevens MC, Rey A, Merks JH, Kelsey A, Gallego S, Haie-Meder C, Martelli H.
    Pediatr Blood Cancer; 2014 Feb 01; 61(2):217-22. PubMed ID: 23997024
    [Abstract] [Full Text] [Related]

  • 5. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD, Fleming JC, Haik BG, Wilson MW.
    Ophthalmic Plast Reconstr Surg; 2011 Feb 01; 27(4):241-6. PubMed ID: 21242849
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of outcomes based on treatment algorithms for rhabdomyosarcoma of the bladder/prostate: combined results from the Children's Oncology Group, German Cooperative Soft Tissue Sarcoma Study, Italian Cooperative Group, and International Society of Pediatric Oncology Malignant Mesenchymal Tumors Committee.
    Rodeberg DA, Anderson JR, Arndt CA, Ferrer FA, Raney RB, Jenney ME, Brecht IB, Koscielniak E, Carli M, Bisogno G, Oberlin O, Rey A, Ullrich F, Stevens MC, Meyer WH.
    Int J Cancer; 2011 Mar 01; 128(5):1232-9. PubMed ID: 20473932
    [Abstract] [Full Text] [Related]

  • 11. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: Report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991.
    Raney RB, Anderson JR, Kollath J, Vassilopoulou-Sellin R, Klein MJ, Heyn R, Glicksman AS, Wharam M, Crist WM, Maurer HM.
    Med Pediatr Oncol; 2000 Jun 01; 34(6):413-20. PubMed ID: 10842248
    [Abstract] [Full Text] [Related]

  • 12. Long-term evaluation of orbital rhabdomyosarcoma in children.
    Boutroux H, Levy C, Mosseri V, Desjardins L, Plancher C, Helfre S, Freneaux P, Cellier C, Orbach D.
    Clin Exp Ophthalmol; 2015 Jun 01; 43(1):12-9. PubMed ID: 24923774
    [Abstract] [Full Text] [Related]

  • 13. Late complications of therapy in 213 children with localized, nonorbital soft-tissue sarcoma of the head and neck: A descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-II and - III. IRS Group of the Children's Cancer Group and the Pediatric Oncology Group.
    Raney RB, Asmar L, Vassilopoulou-Sellin R, Klein MJ, Donaldson SS, Green J, Heyn R, Wharam M, Glicksman AS, Gehan EA, Anderson J, Maurer HM.
    Med Pediatr Oncol; 1999 Oct 01; 33(4):362-71. PubMed ID: 10491544
    [Abstract] [Full Text] [Related]

  • 14. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
    Michalski JM, Meza J, Breneman JC, Wolden SL, Laurie F, Jodoin M, Raney B, Wharam MD, Donaldson SS.
    Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):1027-38. PubMed ID: 15234036
    [Abstract] [Full Text] [Related]

  • 15. Indications for radiotherapy and chemotherapy after complete resection in rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Studies I to III.
    Wolden SL, Anderson JR, Crist WM, Breneman JC, Wharam MD, Wiener ES, Qualman SJ, Donaldson SS.
    J Clin Oncol; 1999 Nov 15; 17(11):3468-75. PubMed ID: 10550144
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors and surgical treatment guidelines for children with rhabdomyosarcoma of the perineum or anus: a report of Intergroup Rhabdomyosarcoma Studies I through IV, 1972 through 1997.
    Blakely ML, Andrassy RJ, Raney RB, Anderson JR, Wiener ES, Rodeberg DA, Paidas CN, Lobe TE, Crist WM, Intergroup Rhabdomyosarcoma Studies I through IV.
    J Pediatr Surg; 2003 Mar 15; 38(3):347-53. PubMed ID: 12632347
    [Abstract] [Full Text] [Related]

  • 17. [Rhabdomyosarcoma in the area of the head-neck. A synopsis of some cases, therapeutic possibilities and prognoses].
    Hess A, Schröder U, Schröder R, Michel O.
    Laryngorhinootologie; 1998 Oct 15; 77(10):557-63. PubMed ID: 9842519
    [Abstract] [Full Text] [Related]

  • 18. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
    Donaldson SS, Meza J, Breneman JC, Crist WM, Laurie F, Qualman SJ, Wharam M, Children's Oncology Group Soft Tissue Sarcoma Committee (formely Intergroup Rhabdomyosarcoma Group) representing the Children's Oncology Group and the Quality Assurance Review Center.
    Int J Radiat Oncol Biol Phys; 2001 Nov 01; 51(3):718-28. PubMed ID: 11597814
    [Abstract] [Full Text] [Related]

  • 19. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98.
    McDowell HP, Foot AB, Ellershaw C, Machin D, Giraud C, Bergeron C.
    Eur J Cancer; 2010 Jun 01; 46(9):1588-95. PubMed ID: 20338746
    [Abstract] [Full Text] [Related]

  • 20. 45 Gy is not sufficient radiotherapy dose for Group III orbital embryonal rhabdomyosarcoma after less than complete response to 12 weeks of ARST0331 chemotherapy: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Ermoian RP, Breneman J, Walterhouse DO, Chi YY, Meza J, Anderson J, Hawkins DS, Hayes-Jordan AA, Parham DM, Yock TI, Donaldson SS, Wolden SL.
    Pediatr Blood Cancer; 2017 Sep 01; 64(9):. PubMed ID: 28548706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.